Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II open-label pilot study of ifosfamide + liposomal doxorubicin followed by radiotherapy as neoadjuvant treatment for high-grade extremity soft tissue sarcoma
2006-005644-92Phase 4Active
- Sponsor
- Antonio Cubillo Gracián (Servicio de OncologÃa Médica - Hospital MD Anderson)
- Start
- Feb 2007
- Modality
- Small Molecules, Liposomes → Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ifosfamide and pegylated liposomal doxorubicin in soft tissue sarcoma (STS), sponsored by Antonio Cubillo Gracián (Servicio de OncologÃa Médica - Hospital MD Anderson). Started Feb 2007; status: active.
02
Drugs
ifosfamidepegylated liposomal doxorubicin
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on 2006-005644-92.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005644-92.